Avidity Biosciences LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Avidity Biosciences LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11328
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Avidity Biosciences LLC (Avidity Biosciences), formerly Avidity NanoMedicines LLC is a biotech company that develops antibody oligonucleotide conjugates (AOCs). The company’s proprietary platform technology has enhanced pharmacokinetic and biodistribution properties that improves the delivery of multiple therapeutic oligonucleotides. Its pipeline of therapeutic programs are intended for the treatment of rare muscle disorders and other serious diseases, including Duchenne muscular dystrophy, myotonic dystrophy and muscle atrophy. The company has research collaborations with leading pharma companies, to discover antibody-based drug candidates against various therapeutic targets. Avidity Biosciences is headquartered in San Diego, California, the US.

Avidity Biosciences LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avidity Biosciences LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Avidity Biosciences LLC, Medical Devices Deals, 2012 to YTD 2018 9
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Avidity Biosciences Raises USD10 Million in Series B Venture Financing 11
Avidity NanoMedicines Raises USD6 Million in Series B Venture Financing 13
Avidity NanoMedicines Raises US$9 Million In Series A Financing 14
Partnerships 15
Sevion Therapeutics Enters into Research Agreement with Avidity NanoMedicines 15
Equity Offering 16
Avidity Biosciences Raises Funds through Private Placement of Equity Financing 16
Avidity Biosciences LLC – Key Competitors 17
Avidity Biosciences LLC – Key Employees 18
Avidity Biosciences LLC – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Key Facts 2
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avidity Biosciences LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avidity Biosciences LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Avidity Biosciences LLC, Medical Devices Deals, 2012 to YTD 2018 9
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Avidity Biosciences Raises USD10 Million in Series B Venture Financing 11
Avidity NanoMedicines Raises USD6 Million in Series B Venture Financing 13
Avidity NanoMedicines Raises US$9 Million In Series A Financing 14
Sevion Therapeutics Enters into Research Agreement with Avidity NanoMedicines 15
Avidity Biosciences Raises Funds through Private Placement of Equity Financing 16
Avidity Biosciences LLC, Key Competitors 17
Avidity Biosciences LLC, Key Employees 18

List of Figures
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avidity Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Avidity Biosciences LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Avidity Biosciences LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • A-Cap Energy Ltd (ACB):企業の財務・戦略的SWOT分析
    Summary A-Cap Energy Ltd (A-Cap) is a mineral resources development company that acquires, explores, and develops mineral resource properties across Australia. It explores for coal and uranium deposits. Its projects include Letlhakane uranium project, the Mea coal project, and Foley coal project. A- …
  • Printpack Inc:企業の戦略的SWOT分析
    Printpack Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Skanray Technologies Pvt Ltd-医療機器分野:企業M&A・提携分析
    Summary Skanray Technologies Pvt Ltd (Skanray) is a medical equipment manufacturing company that provides high frequency x-ray imaging systems, critical care devices, and primary healthcare and telemedicine compatible devices. The company’s product categories include defibrillator, ventilators, surg …
  • Avacta Group Plc (AVCT):製薬・医療:M&Aディール及び事業提携情報
    Summary Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products that include optim and sensipod. It also develops UCB celltech that is an analytical instrument. Avacta’s sensipod is an …
  • Luitpold Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Luitpold Pharmaceuticals Inc (Luitpold Pharmaceuticals), a subsidiary of Daiichi Sankyo Co Ltd is a manufacturer and marketer of drugs and medical devices. The company provides products such as injectable parenteral medications that are used in pharmacy admixtures and nutrient solutions, cri …
  • PhaseRx Inc (PZRX)-医療機器分野:企業M&A・提携分析
    Summary PhaseRx Inc (PhaseRx), formerly PhaseRx Pharmaceuticals Inc is a healthcare products provider that conducts research and develops RNA nanomedicines for the treatment of orphan diseases. The company discovers and develops drugs based on SMARTT polymer technology, which offers mRNA delivery te …
  • Huesker Synthetic GmbH:企業の戦略・SWOT・財務情報
    Huesker Synthetic GmbH - Strategy, SWOT and Corporate Finance Report Summary Huesker Synthetic GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Verizon Communications Inc.:企業のM&A・事業提携・投資動向
    Verizon Communications Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Verizon Communications Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Inovio Pharmaceuticals Inc (INO):企業の財務・戦略的SWOT分析
    Inovio Pharmaceuticals Inc (INO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Abu Dhabi Commercial Bank P.J.S.C.:戦略・SWOT・企業財務分析
    Abu Dhabi Commercial Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Abu Dhabi Commercial Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Aquinox Pharmaceuticals Inc (AQXP)-製薬・医療分野:企業M&A・提携分析
    Summary Aquinox Pharmaceuticals Inc (Aquinox) is a clinical-stage pharmaceutical company which develops targeted therapeutics in the areas of inflammation and immuno-oncology. The company's lead product candidate AQX-1125, is a SHIP1 activator which is a natural modulator of the PI3K pathway to redu …
  • Korea Western Power Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Korea Western Power Co., Ltd. (KOWEPO), a subsidiary of Korea Electric Power Corporation (KEPCO), develops electricity resources, and generates and supplies electricity. The company’s power generation portfolio includes Taen, Pyeongtaek, Seoincheon, and Gunsan power complexes consisting of t …
  • National Fuel Gas Co (NFG):企業の財務・戦略的SWOT分析
    National Fuel Gas Co (NFG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Compagnie Financiere Richemont SA:企業の戦略・SWOT・財務情報
    Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report Summary Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Tetra Technologies, Inc.:企業の戦略・SWOT・財務分析
    Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Calpine Corporation:企業の戦略・SWOT・財務情報
    Calpine Corporation - Strategy, SWOT and Corporate Finance Report Summary Calpine Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Invacare Corporation (IVC)-医療機器分野:企業M&A・提携分析
    Summary Invacare Corporation (Invacare) is a medical equipment company which develops, manufactures and distributes healthcare products for non-acute care, such as the home healthcare and long term care markets. The major products include power wheelchairs, custom manual wheelchairs, personal mobili …
  • The Great-West Life Assurance Co:電力:M&Aディール及び事業提携情報
    Summary The Great-West Life Assurance Co (Great-West Life), a subsidiary of Great-West Lifeco Inc., focuses on life insurance, health insurance, retirement savings, investments, and reinsurance businesses. For individuals, it offers life insurance, disability insurance, critical illness insurance, h …
  • Emerald Expositions, Inc. (EEX):企業の財務・戦略的SWOT分析
    Emerald Expositions, Inc. (EEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Bloomberg LP:企業の戦略的SWOT分析
    Bloomberg LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆